All systems operational
Q2 2024

Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders

Bandar D. Alrehaili
10.4103/sjg.sjg_53_24 389 Views 0 Citations
0
Citations
389
Views
Abstract

Abstract
Bile acids serve as endogenous ligands for nuclear and cell membrane receptors and play a crucial role in bile acid and lipid metabolism. These detergent-like compounds promote bile flow and aid in the absorption of dietary fats and fat-soluble vitamins in the intestine. Synthesized in the liver as end products of cholesterol catabolism, bile acids exhibit a chemical structure comprising a nucleus and a side chain featuring a carboxyl group, with diverse steric arrangements and potential polar substituents. Critical interactions occur between bile acid species and various nuclear and cell membrane receptors, including the farnesoid X receptor and G-protein–coupled bile acid receptor 1. This research aimed to review the literature on bile acids and their roles in treating different diseases. Currently, numerous investigations are concentrating on specific bile acid species that target nuclear receptors in the gastrointestinal system, aiming to improve the treatment of conditions such as nonalcoholic fatty liver disease. Given the global attention this topic has garnered from research groups, it is considered relatively new, thus anticipating some gaps or incomplete data. Bile acid species have a significant therapeutic promise, especially in their ability to activate or inhibit nuclear receptors, such as farnesoid X receptor. This research provides to offer essential information for scientists and medical practitioners interested in discovering new studies that underscore the importance of bile acids in ameliorating and impeding the progression of disorders. Furthermore, it opens avenues for previously overlooked bile acid–based therapies.

Cite this Article (APA)
Bandar, D. A. (2024). Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders. Saudi Journal of Gastroenterology. https://doi.org/10.4103/sjg.sjg_53_24
Related Papers
The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi …
Saleh A. Alqahtani; Faisal Abaalkhail; Saad Alghamdi; Khalid Bzeizi; Waleed K. A · 2024
20
cites
397
CEBPB dampens the cuproptosis sensitivity of colorectal cancer cells by facilitating the PI3K/AKT/mT…
Tianchen Huang; Yong Zhang; Yachao Wu; Xiaodong Han; Lei Li; Zhipeng Guo; Kan Li · 2024
15
cites
398
SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024
Abdullah S. Alghamdi; Hamdan Alghamdi; Haleema A. Alserehi; Mohammed A. Babatin; · 2024
11
cites
396
The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real w…
Nahla Azzam; Othman Alharbi; Mansour Altuwaijri; Yazed Alruthia; Heba Alfarhan; · 2024
9
cites
396
The Saudi Gastroenterology Association consensus on the clinical care pathway for the diagnosis and …
Mohammed A. Alzahrani; Abdullah M. Alqaraawi; Saeed R. Alzubide; Ehab Abufarhane · 2024
7
cites
395
Access
View Full Text via DOI
Published in
ISSN 1319-3767
Quartile Q2
AMS Score 93
Field Medicine & Health Sciences
Publisher Wolters Kluwer / Saudi Gastroentero
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Authors
Publication Details
Year 2024
Language English
Added 23 Jul 2026